<DOC>
	<DOCNO>NCT00462631</DOCNO>
	<brief_summary>The aim study compare efficacy Paclitaxel-eluting PTCA-balloon dilation ( SeQuentTM Please ) follow cobalt-chromium stent ( CoroflexTM Blue ) deployment versus Paclitaxel-eluting stent ( TaxusTM LibertéTM ) deployment treatment de-novo-stenoses native coronary artery ( reference diameter : 2.5 mm 3.5 mm , length stenosis ≥ 10 mm ≤ 20 mm ) patient diabetes mellitus ≥ 3 year procedural success preservation vessel patency . This study prospective , randomize , multi-center , two-armed phase-II pilot study conduct Malaysia Thailand . 128 diabetes mellitus patient shall complete study per protocol random assignment either treatment group order 20 50 patient per center . Diabetes mellitus patient stable select form unstable angina document ischemia due de-novo stenosis native coronary artery enrol . Vessels may supply entirely infarcted myocardial area . Late lumen loss 9 month primary endpoint .</brief_summary>
	<brief_title>Paclitaxel Eluting Balloon Versus Drug Eluting Stent Native Coronary Artery Stenoses Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>History diabetes mellitus least 3 yrs prior enrollment . Diabetes mellitus may treat either orally s.c . Stable blood glucose level 6 month precede enrollment reflect HbA1c concentration measure exclusively ≤ 8 % Patients stable angina pectoris ( CCS class 13 ) unstable angina pectoris ( Braunwald class 12 , AC ) document ischemia document silent ischemia Patients eligible coronary revascularization mean PCI Women childbearing potential may pregnant desire become pregnant first year follow study procedure . Hence , patient advise use adequate birth control method include 6 month followup Patients mentally linguistically able understand aim study show sufficient compliance follow study protocol Patients must agree undergo 9 month angiographic followup Patients must agree undergo 3 year clinical followup Denovo native coronary artery stenosis ( reference diameter : ≥2.5 mm ≤ 3.5 mm , length stenosis : ≥ 10 mm ≤ 20 mm ) Target lesion ≥ 3 mm distant major side branch ( &gt; 2.0 mm diameter ) ≥ 3 mm form previously deploy stent type ( include active passive coating , bare metal stent ) The target lesion must treat single stent ( multiple stenting shifts patient intentiontotreat group ) Single multivessel coronary artery disease Patients acute ( &lt; 24 h ) recent ( 48 hour ) myocardial infarction Patients unstable angina pectoris ( Braunwald class 3 ) Patients severe congestive heart failure Patients severe heart failure NYHA IV Patients severe valvular heart disease Women pregnant lactating Patients another coronary stent implant previously target vessel , drug elute stent less 9 month bare metal stent stent passive coating le 3 month PEPCAD IV DM PCI Patients bleed diathesis anticoagulation antiplatelet medication contraindicate Patients cerebral stroke &lt; 6 month prior procedure Patient participate clinical trial involve investigational device drug Untreated hyperthyroidism Patient presence history severe renal failure ( GFR &lt; 30ml/min ) therefore eligible angiography . Patient 's serum creatinine level must document Post transplantation organ immune suppressive medication Other disease jeopardize followup ( e.g. , malignancy ) Addiction drug alcohol Patients type surgery week precede interventional procedure . Therapy anticoagulant Poorly control diabetes mellitus reflect HbA1c ≥ 8 % six month prior enrollment PEPCAD IV DM Patient history peptic ulcer gastric/intestinal bleeding past 6 month . Evidence extensive thrombosis within target vessel intervention Side branch &gt; 2 mm diameter originate lesion Stent within vessel le 3 mm distant target lesion Multilesion percutaneous coronary intervention within one vessel ( PCI total two lesion one different vessel permit ) Target lesion locate type coronary bypass ( i.e. , venous graft , arterial bypass ) graft/native artery connection Coronary artery occlusion type ( e.g. , acute chronic ) Instent restenosis Insegment restenosis native vessel within 4 mm adjacent target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>coronary artery</keyword>
	<keyword>Diabetes</keyword>
</DOC>